TScan Therapeutics, Inc.TCRXNASDAQ
Loading
ROIC: Returns DecliningContracting
Percentile Rank17
Studio
Year-over-Year Change

Return on invested capital

Latest
-62.51%
↓ 40% vs avg
Percentile
P17
Within normal range
Streak
4 yr
Consecutive declineContracting
Average
-44.62%
Historical baseline
PeriodValueYoY Change
2025-62.51%-57.5%
2024-39.68%-5.7%
2023-37.55%-4.5%
2022-35.93%-24.4%
2021-28.88%+62.9%
2020-77.83%-159.8%
2019-29.96%-